Patents by Inventor Chris A. REID

Chris A. REID has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Riboswitch modulated gene therapy for retinal diseases
    Patent number: 12286631
    Abstract: The present invention provides constructs comprising modified riboswitches to regulate expression of a transgene within a subject. Methods of treating a disease, specifically an eye disease, are also contemplated.
    Type: Grant
    Filed: March 6, 2024
    Date of Patent: April 29, 2025
    Assignee: The Medical College of Wisconsin, Inc.
    Inventors: Daniel M. Lipinski, Chris A. Reid
  • RIBOSWITCH MODULATED GENE THERAPY FOR RETINAL DISEASES
    Publication number: 20240336925
    Abstract: The present invention provides constructs comprising modified riboswitches to regulate expression of a transgene within a subject. Methods of treating a disease, specifically an eye disease, are also contemplated.
    Type: Application
    Filed: March 6, 2024
    Publication date: October 10, 2024
    Inventors: Daniel M. Lipinski, Chris A. Reid
  • Riboswitch modulated gene therapy for retinal diseases
    Patent number: 12012602
    Abstract: The present invention provides constructs comprising modified riboswitches to regulate expression of a transgene within a subject. Methods of treating a disease, specifically an eye disease, are also contemplated.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: June 18, 2024
    Assignee: The Medical College of Wisconsin, Inc.
    Inventors: Daniel M. Lipinski, Chris A. Reid
  • RIBOSWITCH MODULATED GENE THERAPY FOR RETINAL DISEASES
    Publication number: 20240158800
    Abstract: The present invention provides constructs comprising modified riboswitches to regulate expression of a transgene within a subject. Methods of treating a disease, specifically an eye disease, are also contemplated.
    Type: Application
    Filed: July 26, 2023
    Publication date: May 16, 2024
    Inventors: Daniel M. Lipinski, Chris A. Reid
  • RIBOSWITCH MODULATED GENE THERAPY FOR RETINAL DISEASES
    Publication number: 20200063137
    Abstract: The present invention provides constructs comprising modified riboswitches to regulate expression of a transgene within a subject. Methods of treating a disease, specifically an eye disease, are also contemplated.
    Type: Application
    Filed: March 9, 2018
    Publication date: February 27, 2020
    Inventors: Daniel M. LIPINSKI, Chris A. REID